東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁 到查詢結果 [ subject:"Pharmacy- Research." ]

切換: 標籤 | MARC模式 | ISBD

Databases for pharmacoepidemiologica...

Sturkenboom, Miriam.

FindBook

Google Book

Amazon

博客來

Databases for pharmacoepidemiological research

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Databases for pharmacoepidemiological research/ edited by Miriam Sturkenboom, Tania Schink.
其他作者:	Sturkenboom, Miriam.
出版者:	Cham :Springer International Publishing : : 2021.,
面頁冊數:	ix, 280 p. :ill., digital ;24 cm.
Contained By:	Springer Nature eBook
標題:	Drugs - Side effects -
電子資源:	https://doi.org/10.1007/978-3-030-51455-6
ISBN:	9783030514556

Databases for pharmacoepidemiological research
Databases for pharmacoepidemiological research[electronic resource] /edited by Miriam Sturkenboom, Tania Schink. - Cham :Springer International Publishing :2021. - ix, 280 p. :ill., digital ;24 cm. - Springer series on epidemiology and public health,1869-7933. - Springer series on epidemiology and public health..

This book allows readers to gain an in-depth understanding of the role of real-world data in pharmacoepidemiology, and highlights the strengths and limitations of the respective databases with regard to pharmacoepidemiological research. Over the past decade, the increasing use of real-world data in pharmacoepidemiological research has been accompanied by a growing recognition of the value of real-world evidence in clinical and regulatory decision-making. Electronic healthcare databases allow analyses of drug and vaccine utilization in routine care after approval, as well as investigations of their comparative effectiveness and safety. They are especially useful for the identification of rare risks and rare drug exposures over long periods of time, and as such sustainably extend the basis for drug safety research. This book provides an introduction to the role of real-world data in pharmacoepidemiological research and the main developments in the last 15 years. It also offers a comprehensive overview of the general classification characteristics of databases, together with their strengths and limitations, and a detailed description of 21 individual databases, written by professionals who work with or maintain them.

ISBN: 9783030514556

Standard No.: 10.1007/978-3-030-51455-6doiSubjects--Topical Terms:

3490106
Drugs
--Side effects

LC Class. No.: RM302.5 / .D38 2021

Dewey Class. No.: 615.7042

National Library of Medicine Call No.: QV 771

Databases for pharmacoepidemiological research
LDR:02328nmm a2200349 a 4500 001 2237670
003 DE-He213
005 20210112004935.0
006 m d
007 cr nn 008maaau
008 211111s2021 sz s 0 eng d
020 $a 9783030514556 $q (electronic bk.)
020 $a 9783030514549 $q (paper)
024 7 $a 10.1007/978-3-030-51455-6 $2 doi
035 $a 978-3-030-51455-6
040 $a GP $c GP
041 0 $a eng
050 4 $a RM302.5 $b .D38 2021
060 0 0 $a QV 771
072 7 $a PBT $2 bicssc
072 7 $a MED090000 $2 bisacsh
072 7 $a PBT $2 thema
072 7 $a MBNS $2 thema
082 0 4 $a 615.7042 $2 23
090 $a RM302.5 $b .D232 2021
245 0 0 $a Databases for pharmacoepidemiological research $h [electronic resource] / $c edited by Miriam Sturkenboom, Tania Schink.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2021.
300 $a ix, 280 p. : $b ill., digital ; $c 24 cm.
490 1 $a Springer series on epidemiology and public health, $x 1869-7933
520 $a This book allows readers to gain an in-depth understanding of the role of real-world data in pharmacoepidemiology, and highlights the strengths and limitations of the respective databases with regard to pharmacoepidemiological research. Over the past decade, the increasing use of real-world data in pharmacoepidemiological research has been accompanied by a growing recognition of the value of real-world evidence in clinical and regulatory decision-making. Electronic healthcare databases allow analyses of drug and vaccine utilization in routine care after approval, as well as investigations of their comparative effectiveness and safety. They are especially useful for the identification of rare risks and rare drug exposures over long periods of time, and as such sustainably extend the basis for drug safety research. This book provides an introduction to the role of real-world data in pharmacoepidemiological research and the main developments in the last 15 years. It also offers a comprehensive overview of the general classification characteristics of databases, together with their strengths and limitations, and a detailed description of 21 individual databases, written by professionals who work with or maintain them.
650 0 $a Drugs $x Side effects $x Research. $3 3490106
650 0 $a Pharmacoepidemiology $x Data processing. $3 3490107
650 0 $a Pharmacy $x Research. $3 686463
650 2 4 $a Biostatistics. $3 1002712
650 2 4 $a Drug Safety and Pharmacovigilance. $3 2108855
650 2 4 $a Epidemiology. $3 568544
650 1 4 $a Statistics for Life Sciences, Medicine, Health Sciences. $3 891086
700 1 $a Sturkenboom, Miriam. $3 3490104
700 1 $a Schink, Tania. $3 3490105
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer Nature eBook
830 0 $a Springer series on epidemiology and public health. $3 2210413
856 4 0 $u https://doi.org/10.1007/978-3-030-51455-6
950 $a Medicine (SpringerNature-11650)